Type of Study:
Double-blind, placebo controlled trial for glycemic control
About 43 Weeks
18 - 75 Years Old, Male and Femal
Participants will receive at no cost: study product, study materials and study-specific procedures
Staus: Coming soon
The main purpose of this study is to evaluate the efficacy and safety of LY3437943 in participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin.